Copyright
©The Author(s) 2020.
World J Clin Cases. May 6, 2020; 8(9): 1600-1607
Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1600
Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1600
Figure 1 Serum neutrophil gelatinase-associated lipocalin peak in no-cardiorenal syndrome type 1 vs cardiorenal syndrome type 1 patients.
CRS-1: Cardiorenal syndrome type 1; sNGAL: Serum neutrophil gelatinase-associated lipocalin.
- Citation: Ferrari F, Scalzotto E, Esposito P, Samoni S, Mistrorigo F, Rizo Topete LM, De Cal M, Virzì GM, Corradi V, Torregrossa R, Valle R, Bianzina S, Aspromonte N, Floris M, Fontanelli A, Brendolan A, Ronco C. Neutrophil gelatinase-associated lipocalin does not predict acute kidney injury in heart failure. World J Clin Cases 2020; 8(9): 1600-1607
- URL: https://www.wjgnet.com/2307-8960/full/v8/i9/1600.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i9.1600